524627
Phosphatase Inhibitor Cocktail III
liquid, for the inhibition of serine/threonine and protein tyrosine phosphatases
别名:
磷酸酶抑制剂混合物（套装III）
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352200
NACRES:
NA.77
Form:
liquid
Solubility:
water: soluble
Storage temp.:
−20°C
产品名称
磷酸酶抑制剂混合物套装III, Phosphatase Inhibitor Cocktail Set III is a ready to use cocktail of four phosphatase inhibitors for broad-spectrum inhibition of both serine/threonine and protein tyrosine phosphatases.
form
liquid
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze
solubility
water: soluble
shipped in
wet ice
storage temp.
−20°C
Application
磷酸酶抑制剂混合物套装III已用于：
- 作为裂解缓冲液的补充，制备全睾丸蛋白裂解液，进行蛋白质印迹分析
- 强化冷藏裂解放射免疫沉淀（RIPA）缓冲液，均质化幼虫后肠，以进行蛋白质印迹分析
- 作为细胞裂解缓冲液的成分，提取总蛋白用于蛋白质印迹分析
Biochem/physiol Actions
主要靶标
丝氨酸/苏氨酸和蛋白质酪氨酸磷酸酶
丝氨酸/苏氨酸和蛋白质酪氨酸磷酸酶
产物不与ATP竞争。
可逆：否
细胞渗透性：否
Disclaimer
毒性：有毒（F）
Features and Benefits
- 方便的即用型配方
- 高品质的产品，具有一致和可重复的性能
- 灵活选择一系列针对不同类别磷酸酶的混合物
General description
磷酸化和去磷酸化可调节细胞分裂、增殖和凋亡等细胞活动的信号转导过程。蛋白激酶在目标蛋白上的特定氨基酸残基（丝氨酸、苏氨酸或酪氨酸）上添加磷酸基团，改变它们的构象和与配体的相互作用。蛋白质磷酸酶去除磷酸基团，使蛋白质恢复到去磷酸化状态。当从细胞和组织裂解物中提取磷酸化蛋白时，必须保持其磷酸化状态。磷酸酶抑制剂混合物组III是四种磷酸酶抑制剂的混合物，用于广谱抑制丝氨酸/苏氨酸和蛋白质酪氨酸磷酸酶。可以1 ml小瓶或一组5个1 ml小瓶的形式提供。
Other Notes
每瓶含有1 ml水溶液，含有以下成分：
- 50 mM氟化钠
- 10 mMß-甘油三酯（目录号35675）
- 10 mM十水焦磷酸钠
- 1 mM正钒酸钠
Physical form
在H₂O中。
Preparation Note
为了长期储存，分装冻存（-20°C）。临用前按1：5稀释。
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Blockade of Toll-like receptor 4 (TLR4) reduces oxidative stress and restores phospho-ERK1/2 levels in Leydig cells exposed to high glucose
Karpova T, et al.
Life Sciences, 245, 117365-117365 (2020)
HLA-G regulates the invasive properties of JEG-3 choriocarcinoma cells by controlling STAT3 activation
Liu X, et al.
Placenta, 34(11), 1044-1052 (2013)
Sarath Ramachandran et al.
Nature communications, 14(1), 6345-6345 (2023-10-11)
The Src homology 2 (SH2) domain recognizes phosphotyrosine (pY) post translational modifications in partner proteins to trigger downstream signaling. Drug discovery efforts targeting the SH2 domains have long been stymied by the poor drug-like properties of phosphate and its mimetics.
Lucie Knoblochova et al.
EMBO reports, 24(10), e56530-e56530 (2023-09-11)
After fertilization, remodeling of the oocyte and sperm genomes is essential to convert these highly differentiated and transcriptionally quiescent cells into early cleavage-stage blastomeres that are transcriptionally active and totipotent. This developmental transition is accompanied by cell cycle adaptation, such
A targeted genetic modifier screen in Drosophila uncovers vulnerabilities in a genetically complex model of colon cancer
Datta I, et al.
G3: Genes, Genomes, Genetics, 13(5), jkad053-jkad053 (2023)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持